加拿大关于在可切除的非小细胞肺癌中术后系统治疗的观点
Saqib Raza Khan1,2, Enxhi Kotrri2,3, Daniel Breadner1,2
1Division of Medical Oncology, Department of Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 3K7, Canada.
周术策略改善了可切除非小细胞肺癌 (NSCLC) 的结果. 本次审查考察了将免疫疗法和向治疗等新疗法纳入加拿大实践,解决更好的患者护理的实施挑战.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 临床试验 临床试验
背景情况:
- 可切除的非小细胞肺癌 (NSCLC) 管理已经发展.
- 尽管外科手术取得了进展,但复发风险仍然很高.
- 在临床试验中,经手术策略显示出更好的结果.
研究的目的:
- 审查近期临床试验的进展,对早期可操作的NSCLC进行外科手术期间的策略.
- 在加拿大医疗保健框架内将全球进展置于背景中.
- 引导临床医生整合新疗法并应对实施挑战.
主要方法:
- 在术后NSCLC治疗中的里程碑式临床试验的综述.
- 专注于加拿大关于国家实践整合的观点.
- 讨论免疫疗法,辅助向疗法和ctDNA监测.
主要成果:
- 经外科手术的方法显示出更高的反应率,病理结果和生存率.
- 检查点抑制剂和辅助向疗法是关键的进展.
- 基于ctDNA的最小残留疾病监测是一个新兴的工具.
结论:
- 整合外科手术期间的策略对于改善切除性NSCLC患者的治疗结果至关重要.
- 应对加拿大医疗保健系统的挑战 (批准,多学科护理) 是必不可少的.
- 优化患者护理需要适应这些新的治疗范式.
更多相关视频
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014
06:40An In Vivo Mouse Model of Total Intravenous Anesthesia During Cancer Resection Surgery
Published on: June 8, 2021
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
The Behavioral Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
Lung Capacity
